IL1B and acute respiratory distress syndrome: Supporting this, ARDS patients receiving lung protective ventilator strategy have lower levels of alveolar and systemic inflammation, in particular less alveolar neutrophils, and lower levels of the pro-inflammatory cytokines IL-1ß and TNF-α [32].